General Announcement

25/07/2012

MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD (MGRC or Company) - PROPOSED ACQUISITIONS OF UP TO 70 % EQUITY STAKE IN CLINIPATH (MALAYSIA) SDN. BHD., 100% EQUITY STAKE IN CLINIPATH CAPITAL SDN. BHD. AND 100% EQUITY STAKE IN MEDICAL SCAN SDN. BHD. BY MPATH SDN. BHD. ("MPATH") FOR A TOTAL CASH CONSIDERATION OF UP TO RM13,300,000.00. ("PROPOSED ACQUISITIONS"))

MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD

Admission SponsorKenanga Investment Bank Bhd
SponsorSame as above
TypeReply to query
Reply to Bursa Malaysia's Query Letter - Reference IDNM-120723-43396
SubjectMALAYSIAN GENOMICS RESOURCE CENTRE BERHAD (MGRC or Company)
- PROPOSED ACQUISITIONS OF UP TO 70 % EQUITY STAKE IN CLINIPATH (MALAYSIA) SDN. BHD., 100% EQUITY STAKE IN CLINIPATH CAPITAL SDN. BHD. AND 100% EQUITY STAKE IN MEDICAL SCAN SDN. BHD. BY MPATH SDN. BHD. ("MPATH") FOR A TOTAL CASH CONSIDERATION OF UP TO RM13,300,000.00. ("PROPOSED ACQUISITIONS"))
DescriptionMALAYSIAN GENOMICS RESOURCE CENTRE BERHAD (MGRC or Company)
- PROPOSED ACQUISITIONS OF UP TO 70 % EQUITY STAKE IN CLINIPATH (MALAYSIA) SDN. BHD., 100% EQUITY STAKE IN CLINIPATH CAPITAL SDN. BHD. AND 100% EQUITY STAKE IN MEDICAL SCAN SDN. BHD. BY MPATH FOR A TOTAL CASH CONSIDERATION OF UP TO RM13,300,000.00.
Query Letter Contents We refer to your announcement dated 20 July 2012 in respect of the above matter.
In this connection, kindly furnish Bursa Malaysia Securities Berhad ("Bursa
Securities") with the following additional information for public release:-

The latest audited net profits and net assets of CM, CC and MS respectively.
Particulars of contingent liabilities and guarantees to be assumed by your
Company/MPath Sdn Bhd arising from the Proposed Acquisition.
The estimated time frame for submission of the application for the relevant
authorities' approval on the Proposed Acquisition.
Effect of the Proposed Acquisition on MGRC group's earnings per share for the
financial year ending 30 June 2013.
Effect of the Proposed Acquisition on the net assets per share and gearing of
the MGRC group, based on its latest audited accounts as at 30 June 2011.
To quantify the First Payment, Second Payment and Third Payment.
The source(s) of funding for MGRC's portion of the cash contribution to MPath
Sdn Bhd in order for MPath to finance the Proposed Acquisition.
Details of the profit incentive for the Clinipath group of up to RM2,200,000
for the relevant financial year.
Please furnish Bursa Securities with your reply within one (1) market day from
the date hereof.

Yours faithfully


TAN YEW ENG
Head, Issuers
Listing Division, Regulation
TYE/NMA
c.c:- Head, Market Surveillance Department, Market Supervision Division,
Securities Commission (via fax)


Announcement Info

Company NameMALAYSIAN GENOMICS RESOURCE CENTRE BERHAD (ACE Market) 
Stock Name MGRC
Date Announced25 Jul 2012  
CategoryGeneral Announcement
Reference NoCS-120725-64754

Related Announcements for MGRC
Date Title
07/11/2014 MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" or "the Company") - PROJECT AGREEMENT
04/11/2014 OTHERS MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" or "the Company") - PROJECT AGREEMENT
23/10/2014 OTHERS MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" or "the Company") - Proposed Renewal of Existing Shareholders' Mandate for Recurrent Related Party Transactions of a Revenue or Trading Nature
27/06/2014 MEMORANDUM OF UNDERSTANDING MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" or "the Company") - MEMORANDUM OF UNDERSTANDING BETWEEN FELDA WELLNESS CORPORATION SDN. BHD. AND THE COMPANY
17/02/2014 OTHERS MALAYSIAN GENOMICS RESOURCE BERHAD (“MGRCB” OR “THE COMPANY”) - ACQUISITION OF UP TO 30% EQUITY STAKE IN CLINIPATH (MALAYSIA) SDN BHD (“CM”) FOR A CASH CONSIDERATION OF AN AMOUNT EQUIVALENT APPROXIMATELY TO RM5,429,188.22 BY MPATH SDN. BHD., AN ENTITY JOINTLY CONTROLLED BY AJMAKS SDN BHD (“AJMAKS”) AND MGRCB (“ACQUISITION”)
19/12/2013 OTHERS MALAYSIAN GENOMICS RESOURCE BERHAD (“MGRCB” OR “THE COMPANY”) PROPOSED ACQUISITION OF UP TO 30% EQUITY STAKE IN CLINIPATH (MALAYSIA) SDN BHD (“CM”) FOR A CASH CONSIDERATION OF AN AMOUNT EQUIVALENT APPROXIMATELY TO RM5,429,188.22 BY MPATH SDN. BHD., AN ENTITY JOINTLY CONTROLLED BY AJMAKS SDN BHD (“AJMAKS”) AND MGRCB (“PROPOSED ACQUISITION”)
18/10/2013 MULTIPLE PROPOSALS MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" or "the Company") - Proposed Renewal of Existing Shareholders' Mandate for Recurrent Related Party Transactions of a Revenue or Trading Nature; - Proposed Increase in Authorised Share Capital; and - Proposed Amendments to the Memorandum of Association
05/12/2012 OTHERS MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD (“MGRC” or “Company”) – SUPPLEMENTAL AGREEMENT
03/12/2012 OTHERS MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD (“MGRC” or “Company”) – SUPPLEMENTAL AGREEMENT
03/12/2012 OTHERS MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD (“MGRC” OR “THE COMPANY”) - ADDITIONAL SUBSCRIPTION OF SHARES IN MPATH SDN. BHD., A SUBSIDIARY OF MGRC